• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS CYFRA 21-1; CYTOKERATIN FRAGMENTS 21-1 EIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS CYFRA 21-1; CYTOKERATIN FRAGMENTS 21-1 EIA Back to Search Results
Catalog Number 11820966122
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/28/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The investigation is ongoing.
 
Event Description
The initial reporter received questionable cyfra 21-1 elecsys results for 13 patient samples on a cobas e 411 immunoassay analyzer, serial number (b)(4).The results were reported outside of the laboratory.
 
Manufacturer Narrative
The investigation found that the lumipulse results and abbott architect results are comparable and the elecsys results were found to be higher.The results from the investigation indicated that the higher results for samples numbers 37 and 41 were recorded with the competitor assays as well.Product labeling states: "the measured cyfra 21-1 value of a patient¿s sample can vary depending on the testing procedure used.The laboratory finding must therefore always contain a statement on the cyfra 21-1 assay method used.Cyfra 21-1 values determined on patient samples by different testing procedures cannot be directly compared with one another and could be the cause of erroneous medical interpretations.If there is a change in the cyfra 21-1 assay procedure used while monitoring therapy, then the cyfra 21-1 values obtained upon changing over to the new procedure must be confirmed by parallel measurements with both methods." the investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS CYFRA 21-1
Type of Device
CYTOKERATIN FRAGMENTS 21-1 EIA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10727186
MDR Text Key212846685
Report Number1823260-2020-02631
Device Sequence Number1
Product Code OVK
Combination Product (y/n)N
PMA/PMN Number
K160915
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 12/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number11820966122
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Date Manufacturer Received09/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-